Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2003
11/12/2003EP1255564B1 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies
11/12/2003EP1094815B1 Farnesyl protein transferase inhibitors for treating arthropathies
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/12/2003EP0817650B1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/12/2003EP0759759B1 P75 tnf receptor promoters
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455772A Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop and nasal drop
11/12/2003CN1455766A Novel 1,2-diphenylethene derivatives for treatment of immune diseases
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455673A Antibiotics from bacteria isolated from amphibian skin and biological active extrat derivated from same
11/12/2003CN1454626A Chinese herbal medicine for enhancing immunity
11/12/2003CN1454589A Coenzyme Q10 aseptic freee-drying preparation for injection and its preparing method
11/12/2003CN1127515C Process for preparing certain AzA
11/12/2003CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127487C Phthalazinone and its use, and drug containing same
11/12/2003CN1127486C Phthalazine derivatives phosphodiesterase 4 inhibitors
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646108 Process for isolating IgG and IgA
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645983 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645970 Preventing T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer
11/11/2003US6645957 Useful in preventing and treating allergic immunological diseases; treating asthma, atopic dermatitis, allergic rhinitis, inflammatory large bowel disease, contact dermatitis
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645740 Nucleic acids encodings equine GM-CSF
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645495 Compositions of saponin adjuvants and excipients
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003CA2144967C Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091424A1 Method of screening agonistic antibody
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091383A2 Epha2 antigen t epitopes
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091245A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism
11/06/2003WO2003091242A1 Novel thiol derivative, process for producing the same and use thereof
11/06/2003WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003090912A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
11/06/2003WO2003090788A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
11/06/2003WO2003090774A1 Mannose binding lectin and uses thereof
11/06/2003WO2003090766A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans
11/06/2003WO2003090751A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003090734A1 Tolterodine salts
11/06/2003WO2003090726A2 Chewable soft capsule
11/06/2003WO2003090708A1 External preparation for skin
11/06/2003WO2003090676A2 Immunogenic agent therapy using plasmapheresis or exchange transfusion
11/06/2003WO2003090667A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003WO2003090665A2 Regulation of erythrocyte apoptosis
11/06/2003WO2003090664A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
11/06/2003WO2003080114A3 Imidazoquinoline adjuvants for vaccines
11/06/2003WO2003080112A3 Imidazoquinolineamines as adjuvants in hiv dna vaccination
11/06/2003WO2003075685A3 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
11/06/2003WO2003057166A3 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003WO2003048327A3 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003035004A3 Immunotherapy for reversing immune suppression
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003026561A3 Flavonoids for treatment of diabetes
11/06/2003WO2003018640A3 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
11/06/2003WO2003009855A3 Organo-phosphorous compounds for activating gamma/delta t cells
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003WO2003002135A3 Herbal composition
11/06/2003WO2003002125A3 Combination of aminosugars and cysteine or cysteine derivatives
11/06/2003WO2002092773A3 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002066429A8 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002060949A8 Glycoforms a fas ligand inhibitory protein analog
11/06/2003WO2002060900A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
1 ... 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 ... 1172